Clearstead Advisors’s Centene CNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$268K Sell
4,169
-16,060
-79% -$859K ﹤0.01% 965
2026
Q1
$662K Sell
20,229
-7,678
-28% -$315K 0.01% 645
2025
Q4
$1.15M Buy
27,907
+14,520
+108% +$544K 0.01% 439
2025
Q3
$478K Buy
13,387
+11,677
+683% +$353K 0.01% 646
2025
Q2
$92.8K Sell
1,710
-129
-7% -$7.57K ﹤0.01% 1086
2025
Q1
$112K Buy
1,839
+1,808
+5,832% +$109K ﹤0.01% 973
2024
Q4
$1.85K Sell
31
-150
-83% -$9.35K ﹤0.01% 1852
2024
Q3
$13.6K Sell
181
-219
-55% -$16.1K ﹤0.01% 1523
2024
Q2
$26.5K Sell
400
-104
-21% -$7.57K ﹤0.01% 1301
2024
Q1
$38.9K Sell
504
-37
-7% -$2.86K ﹤0.01% 830
2023
Q4
$40.1K Buy
541
+37
+7% +$2.67K ﹤0.01% 798
2023
Q3
$34.7K Hold
504
﹤0.01% 786
2023
Q2
$34K Sell
504
-5,438
-92% -$363K ﹤0.01% 811
2023
Q1
$376K Buy
5,942
+111
+2% +$7.88K 0.03% 304
2022
Q4
$478K Hold
5,831
0.04% 261
2022
Q3
$454K Hold
5,831
0.04% 237
2022
Q2
$493K Hold
5,831
0.04% 253
2022
Q1
$491K Buy
+5,831
New +$478K 0.03% 269

Other funds holding CNC

Clearstead Advisors's CNC Position: Q2 2026 in Review

Clearstead Advisors reduced its Centene (CNC) stake by 79% in Q2 2026, selling an estimated $859K and leaving 4,169 shares worth $268K. The position accounts for ﹤0.01% of the portfolio, ranked #965.

Clearstead Advisors first reported a position in CNC in Q1 2022 and has held it in 18 quarters since. The position peaked at $1.15M in Q4 2025. 1,004 funds tracked by Wall St. Rank hold CNC as of Q2 2026.

  • Clearstead Advisors held 4,169 shares of Centene worth $268K as of Q2 2026.
  • Clearstead Advisors sold 16,060 Centene shares in Q2 2026, an estimated $859K.
  • Centene made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #965 holding.
  • Clearstead Advisors first reported a position in Centene in Q1 2022 and has held it in 18 quarters since.
  • Clearstead Advisors's Centene position peaked at $1.15M in Q4 2025.
  • 1,004 funds tracked by Wall St. Rank held Centene as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.